Epidemiology

Bimodal age distribution; mostly affects children (between the ages of 3–12 years) and patients > 60 years of age


Etiology

  • Prior infection with group A beta-hemolytic streptococci (GAS, S pyogenes)
    • In children
      • Infection of the mouth and pharynx (tonsillitis, pharyngitis): PSGN typically arises 1–2 weeks following infection.
      • Soft tissue infections (erysipelas, impetigo): PSGN typically arises 4–6 weeks following infection.

Pathophysiology

Infection with nephritogenic strains of group A beta-hemolytic streptococci → streptococcal antigen deposit within the glomerular basement membrane → immune complexes formation (Type III hypersensitivity reaction)complement activation (↑ consumption of complement factors) → destruction of the glomeruli → immune complex-mediated glomerulonephritis and nephritic syndrome


Clinical features

Approx. 50% of patients remain asymptomatic. Symptoms occur approximately 1–6 weeks following an acute infection.


Diagnostics

Initial evaluation

Tip

If both C3 and C4 complement levels are decreased, consider other causes of glomerulonephritis with low serum complement levels and possible nonrenal causes of low complement levels (e.g., liver failure, nonrenal protein-losing conditions).

Evidence of preceding GAS infection

  • Antistreptococcal antibody titers
    • Findings: ↑ ASO, ↑ anti-DNase B antibodies
  • Isolation of group A beta-hemolytic streptococci
    • Pharyngitis: rapid strep test, throat culture
    • Skin lesions: wound cultures

Microscopy

  • LM: hypercellular glomeruli

Treatment


Prognosis


Increased age is the most important poor prognostic factor t

  • Children: Excellent prognosis; >95% recover completely with conservative management.
  • Adults: Worse prognosis; higher risk of progressing to Rapidly Progressive Glomerulonephritis (RPGN) or Chronic Kidney Disease (CKD).